CN1596113B - δ受体激动剂化合物在制备治疗抑郁症的药物中的应用 - Google Patents

δ受体激动剂化合物在制备治疗抑郁症的药物中的应用 Download PDF

Info

Publication number
CN1596113B
CN1596113B CN028237099A CN02823709A CN1596113B CN 1596113 B CN1596113 B CN 1596113B CN 028237099 A CN028237099 A CN 028237099A CN 02823709 A CN02823709 A CN 02823709A CN 1596113 B CN1596113 B CN 1596113B
Authority
CN
China
Prior art keywords
composition
formula
mood disorder
treating
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN028237099A
Other languages
English (en)
Chinese (zh)
Other versions
CN1596113A (zh
Inventor
张宽仁
威廉·彭德格斯特
彼得·J·真戈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wersi Refco Group Ltd
Original Assignee
Mount Cook Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Cook Biosciences Inc filed Critical Mount Cook Biosciences Inc
Publication of CN1596113A publication Critical patent/CN1596113A/zh
Application granted granted Critical
Publication of CN1596113B publication Critical patent/CN1596113B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN028237099A 2001-10-29 2002-10-29 δ受体激动剂化合物在制备治疗抑郁症的药物中的应用 Expired - Fee Related CN1596113B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US34008401P 2001-10-29 2001-10-29
US60/340,084 2001-10-29
US33788701P 2001-11-02 2001-11-02
US60/337,887 2001-11-02
PCT/US2002/034421 WO2003037342A1 (en) 2001-10-29 2002-10-29 Method of treating depression with delta receptor agonist compounds

Publications (2)

Publication Number Publication Date
CN1596113A CN1596113A (zh) 2005-03-16
CN1596113B true CN1596113B (zh) 2010-05-26

Family

ID=26990913

Family Applications (1)

Application Number Title Priority Date Filing Date
CN028237099A Expired - Fee Related CN1596113B (zh) 2001-10-29 2002-10-29 δ受体激动剂化合物在制备治疗抑郁症的药物中的应用

Country Status (11)

Country Link
US (1) US7030124B2 (https=)
EP (1) EP1450807B1 (https=)
JP (1) JP4892654B2 (https=)
CN (1) CN1596113B (https=)
CA (1) CA2464471C (https=)
MX (1) MXPA04004059A (https=)
NO (1) NO20042257L (https=)
PL (1) PL371297A1 (https=)
RU (1) RU2314809C2 (https=)
TW (1) TW200300089A (https=)
WO (1) WO2003037342A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1395567T3 (da) * 2001-05-18 2009-04-06 Astrazeneca Ab 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
CN101921279A (zh) 2003-10-01 2010-12-22 阿得罗公司 螺环杂环衍生物及其应用方法
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
DK1781631T3 (da) * 2004-08-02 2012-05-14 Astrazeneca Ab Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
TW200724144A (en) * 2005-04-14 2007-07-01 Ardent Pharmaceuticals Inc Compositions of novel opioid compounds and method of use thereof
TW200803856A (en) 2005-09-02 2008-01-16 Mount Cook Biosciences Inc Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EA201001644A1 (ru) * 2008-05-20 2011-06-30 Астразенека Аб Способ лечения тревожного большого депрессивного расстройства
CN103467460A (zh) * 2013-09-23 2013-12-25 昆明理工大学 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用
CN105646151B (zh) * 2016-02-26 2018-06-29 山西大学 一种炔类化合物及其制备方法和该化合物的用途
US10973815B2 (en) 2016-03-31 2021-04-13 Versi Group, Llc Delta opioid agonist mu opioid antagonist compositions and methods for treating Parkinsons disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658908A (en) * 1992-02-03 1997-08-19 Delta Pharmaceuticals, Inc. Opioid diarylmethylpiperazines and piperdines

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US5985880A (en) 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US20020052007A1 (en) * 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5574159A (en) 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
CN1054850C (zh) * 1993-07-30 2000-07-26 德尔塔药物公司 用于治疗的哌嗪化合物
US6046200A (en) 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9804734D0 (en) 1998-03-05 1998-04-29 Pfizer Ltd Compounds
ES2226284T3 (es) * 1998-04-16 2005-03-16 Pfizer Products Inc. N-acil y n-aroil-aralquilamidas.
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
GB0017256D0 (en) 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
DK1395567T3 (da) 2001-05-18 2009-04-06 Astrazeneca Ab 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658908A (en) * 1992-02-03 1997-08-19 Delta Pharmaceuticals, Inc. Opioid diarylmethylpiperazines and piperdines

Also Published As

Publication number Publication date
EP1450807B1 (en) 2013-12-25
NO20042257L (no) 2004-06-24
MXPA04004059A (es) 2005-03-31
JP4892654B2 (ja) 2012-03-07
RU2314809C2 (ru) 2008-01-20
WO2003037342A1 (en) 2003-05-08
PL371297A1 (en) 2005-06-13
CA2464471A1 (en) 2003-05-08
EP1450807A1 (en) 2004-09-01
CA2464471C (en) 2012-05-15
TW200300089A (en) 2003-05-16
US20030144299A1 (en) 2003-07-31
US7030124B2 (en) 2006-04-18
JP2005508363A (ja) 2005-03-31
CN1596113A (zh) 2005-03-16
EP1450807A4 (en) 2008-06-25
RU2004115748A (ru) 2005-03-27

Similar Documents

Publication Publication Date Title
CN1596113B (zh) δ受体激动剂化合物在制备治疗抑郁症的药物中的应用
ES2892954T3 (es) Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos
US5985880A (en) Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
CA2257393C (en) Compositions and methods for reducing respiratory depression
US9296707B2 (en) Delta opioid receptor agonist compounds
CN103929961A (zh) 化合物及其治疗应用
US20020052007A1 (en) Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
CN100508980C (zh) 利用δ阿片受体促效药来防止下泌尿系功能障碍的组合物
CN101198330A (zh) 新阿片类化合物的组合物及其使用方法
EP1438051A1 (en) An enantiomerically pure diarylmethylpiperazine and methods of using same
AU2002341832A1 (en) An enantiomerically pure diarylmethylpiperazine and methods of using same
CN100435796C (zh) 保护心脏的δ类阿片受体激动剂和该激动剂在制备药物中的应用
AU2002353896B2 (en) Method of treating depression with delta receptor agonist compounds
WO2026012523A2 (zh) 钠通道调节剂
MXPA00000195A (en) Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
AU2002353896A1 (en) Method of treating depression with delta receptor agonist compounds

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1076032

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: VERMONT COOK BIOLOGICAL SCIENCE CO., LTD.

Free format text: FORMER OWNER: ARDENT PHARMACEUTICALS INC.

Effective date: 20071102

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20071102

Address after: American New York

Applicant after: MOUNT COOK BIOSCIENCES, Inc.

Address before: North Carolina

Applicant before: ARDENT PHARMACEUTICALS, Inc.

C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: WYLCI IBRAHIM

Free format text: FORMER OWNER: MT. COOK PHARMA, INC.

Effective date: 20120319

C41 Transfer of patent application or patent right or utility model
C56 Change in the name or address of the patentee

Owner name: MT. COOK PHARMA, INC.

Free format text: FORMER NAME: MOUNT COOK BIOSCIENCES INC.

CP01 Change in the name or title of a patent holder

Address after: New York, USA

Patentee after: MT. Cook pharmaceuticals

Address before: New York, USA

Patentee before: MOUNT COOK BIOSCIENCES, Inc.

TR01 Transfer of patent right

Effective date of registration: 20120319

Address after: New jersey, USA

Patentee after: Ibrahim Velsi

Address before: New York, USA

Patentee before: MT. Cook pharmaceuticals

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1076032

Country of ref document: HK

ASS Succession or assignment of patent right

Owner name: WEIERXI GROUP CO., LTD.

Free format text: FORMER OWNER: WYLCI IBRAHIM

Effective date: 20131119

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20131119

Address after: New jersey, USA

Patentee after: Wersi Refco Group Ltd.

Address before: New jersey, USA

Patentee before: Ibrahim Velsi

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100526

Termination date: 20171029

CF01 Termination of patent right due to non-payment of annual fee